B. Riley Comments on RadNet’s FY2026 Earnings (NASDAQ:RDNT)

RadNet, Inc. (NASDAQ:RDNT) – Analysts at B. Riley issued their FY2026 EPS estimates for shares of RadNet in a research note issued on Sunday, November 30th. B. Riley analyst Y. Zhi expects that the medical research company will post earnings per share of $0.70 for the year. B. Riley has a “Buy” rating and a $87.00 price objective on the stock. The consensus estimate for RadNet’s current full-year earnings is $0.56 per share.

Several other research firms have also weighed in on RDNT. Zacks Research lowered RadNet from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 12th. Raymond James Financial reiterated a “strong-buy” rating and issued a $95.00 target price on shares of RadNet in a report on Friday, November 14th. Morgan Stanley raised RadNet to an “overweight” rating in a research note on Monday, August 11th. Barclays raised their price objective on shares of RadNet from $79.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Truist Financial boosted their target price on shares of RadNet from $81.00 to $90.00 and gave the company a “buy” rating in a research report on Wednesday, November 12th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $87.60.

RadNet Price Performance

RDNT stock opened at $79.46 on Tuesday. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt-to-equity ratio of 0.82. The firm has a market cap of $6.13 billion, a price-to-earnings ratio of -467.38 and a beta of 1.49. The company’s fifty day simple moving average is $78.25 and its 200 day simple moving average is $67.61. RadNet has a 12-month low of $45.00 and a 12-month high of $85.84.

RadNet (NASDAQ:RDNT) last posted its quarterly earnings data on Monday, November 10th. The medical research company reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.03). RadNet had a negative net margin of 0.65% and a positive return on equity of 2.52%. The firm had revenue of $522.87 million during the quarter, compared to the consensus estimate of $494.19 million. During the same period in the prior year, the company posted $0.18 earnings per share. The company’s revenue for the quarter was up 13.4% compared to the same quarter last year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Headlands Technologies LLC acquired a new position in shares of RadNet during the first quarter valued at about $28,000. Allworth Financial LP raised its holdings in shares of RadNet by 346.6% in the 3rd quarter. Allworth Financial LP now owns 393 shares of the medical research company’s stock worth $30,000 after acquiring an additional 305 shares during the last quarter. Danske Bank A S bought a new position in RadNet in the 3rd quarter valued at about $30,000. Farther Finance Advisors LLC lifted its position in RadNet by 1,086.5% in the 3rd quarter. Farther Finance Advisors LLC now owns 439 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 402 shares in the last quarter. Finally, Jones Financial Companies Lllp boosted its stake in RadNet by 62.2% during the 3rd quarter. Jones Financial Companies Lllp now owns 446 shares of the medical research company’s stock valued at $34,000 after purchasing an additional 171 shares during the last quarter. Institutional investors and hedge funds own 77.90% of the company’s stock.

Insider Transactions at RadNet

In other RadNet news, EVP Mark Stolper sold 35,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $73.89, for a total value of $2,586,150.00. Following the completion of the sale, the executive vice president owned 68,012 shares of the company’s stock, valued at approximately $5,025,406.68. This trade represents a 33.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Mital Patel sold 15,080 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $80.05, for a total value of $1,207,154.00. Following the transaction, the chief accounting officer directly owned 180,138 shares in the company, valued at $14,420,046.90. The trade was a 7.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 96,000 shares of company stock worth $7,287,864. 5.60% of the stock is currently owned by insiders.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.